Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 04:00PM ET
5.56
Dollar change
-0.17
Percentage change
-2.97
%
IndexRUT P/E- EPS (ttm)-6.38 Insider Own7.23% Shs Outstand118.79M Perf Week3.93%
Market Cap660.47M Forward P/E- EPS next Y-0.80 Insider Trans0.00% Shs Float110.21M Perf Month-14.72%
Income-548.92M PEG- EPS next Q0.16 Inst Own52.95% Short Float / Ratio37.33% / 4.77 Perf Quarter-33.49%
Sales1.05B P/S0.63 EPS this Y56.61% Inst Trans3.93% Short Interest41.15M Perf Half Y-30.93%
Book/sh-5.71 P/B- EPS next Y78.19% ROA-27.97% Target Price20.20 Perf Year-66.59%
Cash/sh5.57 P/C1.00 EPS next 5Y- ROE- 52W Range5.30 - 18.55 Perf YTD-45.91%
Dividend- P/FCF- EPS past 5Y7.76% ROI- 52W High-70.03% Beta1.58
Dividend %- Quick Ratio0.64 Sales past 5Y525.36% Gross Margin65.94% 52W Low4.91% ATR0.39
Employees1992 Current Ratio0.69 Sales Q/Q-74.55% Oper. Margin-58.32% RSI (14)37.35 Volatility5.55% 6.20%
OptionableYes Debt/Eq- EPS Q/Q41.30% Profit Margin-52.29% Rel Volume0.80 Prev Close5.73
ShortableYes LT Debt/Eq- EarningsNov 09 BMO Payout- Avg Volume8.63M Price5.56
Recom2.50 SMA20-11.09% SMA50-16.60% SMA200-26.48% Volume6,948,410 Change-2.97%
Date Action Analyst Rating Change Price Target Change
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
Feb-23-22Reiterated B. Riley Securities Buy $315 → $265
Feb-22-22Resumed Jefferies Buy $198
Today 11:53AM
Nov-28-23 02:55PM
06:28AM
06:07AM
06:00AM
07:00AM Loading…
Nov-23-23 07:00AM
Nov-22-23 10:44AM
Nov-17-23 07:15AM
Nov-15-23 05:20AM
Nov-11-23 05:30AM
Nov-10-23 01:28PM
09:25AM
09:06AM
Nov-09-23 11:28AM
10:57AM
09:40AM Loading…
09:40AM
08:22AM
08:06AM
08:00AM
07:52AM
01:00AM
Nov-02-23 10:00AM
09:25AM
Nov-01-23 03:10PM
10:43AM
Oct-31-23 04:37PM
12:58PM
Oct-18-23 08:05AM
08:00AM
Oct-17-23 10:17AM
06:00AM Loading…
06:00AM
Oct-16-23 04:07PM
03:34PM
08:01AM
07:13AM
06:34AM
Oct-15-23 12:57AM
12:21AM
12:00AM
Oct-13-23 01:38PM
09:47AM
09:31AM
09:29AM
Oct-12-23 06:00AM
Oct-11-23 08:00AM
Oct-10-23 12:04PM
09:06AM
Oct-09-23 12:25PM
12:01PM
Oct-07-23 05:30AM
Oct-06-23 06:00AM
04:59AM
Oct-05-23 10:58AM
10:21AM
Oct-04-23 02:51PM
01:37PM
11:38AM
11:19AM
09:41AM
07:18AM
Oct-03-23 04:47PM
04:36PM
04:36PM
04:18PM
04:01PM
03:50PM
03:31PM
03:12PM
03:11PM
02:42PM
02:40PM
11:29AM
Sep-28-23 01:11PM
Sep-26-23 01:30PM
Sep-25-23 01:34PM
Sep-21-23 09:39AM
07:30AM
Sep-19-23 01:13PM
Sep-15-23 09:35AM
Sep-14-23 09:37AM
05:00AM
Sep-13-23 10:07AM
08:12AM
04:51AM
Sep-12-23 05:22PM
02:03PM
10:26AM
09:33AM
06:00AM
Sep-11-23 04:03PM
02:12PM
02:07PM
Sep-08-23 04:31PM
12:24PM
12:00PM
Sep-07-23 11:55AM
11:31AM
11:20AM
Sep-06-23 01:16PM
01:06PM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipPresident, R&DNov 05Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
Dubovsky FilipPresident, R&DSep 16Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM
Dubovsky FilipPresident, R&DJun 16Option Exercise8.044,15533,40647,065Jun 21 04:40 PM
Glenn Gregory MPresident, R&DMar 10Option Exercise6.526,29841,06320,771Mar 14 05:16 PM
Trizzino JohnEVP, CCO and CBOMar 10Option Exercise6.524,60930,05111,531Mar 14 05:20 PM
Kelly James PatrickEVP, CFO and TreasurerMar 10Option Exercise6.524,60930,0515,832Mar 14 05:19 PM
Herrmann John A IIIEVP, Chief Legal OfficerMar 10Option Exercise6.524,60930,05113,058Mar 14 05:18 PM
Glenn Gregory MPresident, R&DMar 10Buy6.501,0006,50014,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 07Buy7.042,00014,08813,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 06Buy7.483,00022,45411,473Mar 14 05:16 PM